The FDA has decided to remove black box warnings from hormone therapies for menopause, citing updated research and the need for improved patient access.
New FDA guidelines complicate access to COVID-19 vaccines, especially for younger, healthier individuals, while imposing new requirements in several states.
The FDA has updated COVID-19 vaccine eligibility, restricting access for younger individuals while maintaining availability for seniors and high-risk populations.